Clinical trial
Improving the Humoral Response to Influenza Vaccine in Lung Transplant…
NCT00402805 · University Health Network, Toronto, Other · Completed
Key facts
| NCT number | NCT00402805 |
|---|---|
| Title | Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy |
| Official title | Improving the Humoral Response to Influenza Vaccine in Lung Transplant Recipients by an Intradermal Strategy |
| Lead sponsor | University Health Network, Toronto, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Lung Transplantation, Influenza Vaccines |
| Intervention type | Biological |
| Interventions | Trivalent Inactivated Influenza Vaccine |
| Enrollment | 50 |
| Start date | Oct 1, 2006 |
| Primary completion | Feb 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Nov 22, 2006 |
| Last update posted | Apr 16, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: